Benli Su

1.5k total citations
31 papers, 808 citations indexed

About

Benli Su is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Benli Su has authored 31 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Benli Su's work include Diabetes Treatment and Management (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Benli Su is often cited by papers focused on Diabetes Treatment and Management (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Benli Su collaborates with scholars based in China, Australia and Philippines. Benli Su's co-authors include Sergio Muñoz, Sylvie Franckhauser, Alba Casellas, Anna Pujol, Pedro J. Otaegui, Fátima Bosch, Efrén Riu, Dayi Hu, Changyu Pan and Qiuhe Ji and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Benli Su

29 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benli Su China 12 380 307 249 156 119 31 808
Kalliopi Pafili Greece 14 291 0.8× 170 0.6× 212 0.9× 334 2.1× 165 1.4× 39 875
Gwanpyo Koh South Korea 17 348 0.9× 217 0.7× 226 0.9× 127 0.8× 167 1.4× 57 939
Athanasios Raptis Greece 15 323 0.8× 256 0.8× 140 0.6× 99 0.6× 103 0.9× 39 1.0k
Sang‐Hyun Lee South Korea 20 160 0.4× 296 1.0× 239 1.0× 180 1.2× 116 1.0× 63 973
Ehtasham Ahmad United Kingdom 8 365 1.0× 252 0.8× 244 1.0× 119 0.8× 138 1.2× 20 834
Maimaiti Yisireyili Japan 17 126 0.3× 344 1.1× 158 0.6× 86 0.6× 116 1.0× 26 973
Tomás Meroño Argentina 16 218 0.6× 243 0.8× 192 0.8× 95 0.6× 140 1.2× 66 833
Pier Marco Piatti Italy 18 230 0.6× 149 0.5× 314 1.3× 133 0.9× 132 1.1× 32 1.0k
A. Giancaterini Italy 11 313 0.8× 240 0.8× 382 1.5× 159 1.0× 208 1.7× 20 891
Pablo Stiefel Spain 18 165 0.4× 150 0.5× 150 0.6× 98 0.6× 177 1.5× 60 927

Countries citing papers authored by Benli Su

Since Specialization
Citations

This map shows the geographic impact of Benli Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benli Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benli Su more than expected).

Fields of papers citing papers by Benli Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benli Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benli Su. The network helps show where Benli Su may publish in the future.

Co-authorship network of co-authors of Benli Su

This figure shows the co-authorship network connecting the top 25 collaborators of Benli Su. A scholar is included among the top collaborators of Benli Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benli Su. Benli Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tian, Huiqin, Shiqi Wang, Yating Deng, et al.. (2022). Fatty Acid Profiles and Their Association With Autoimmunity, Insulin Sensitivity and β Cell Function in Latent Autoimmune Diabetes in Adults. Frontiers in Endocrinology. 13. 916981–916981. 2 indexed citations
3.
Cai, Xiaoling, Dayi Hu, Changyu Pan, et al.. (2019). The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study. Scientific Reports. 9(1). 7709–7709. 22 indexed citations
4.
Chen, Ming, Lu Xu, Nan Li, et al.. (2018). Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study. International Journal of Medical Sciences. 15(3). 228–237. 15 indexed citations
5.
Kavalcı, Cemil, et al.. (2017). Treatment with lipid emulsion decreases high levels of phenytoin in rats. Biomedical Research-tokyo. 25–29.
6.
Zhang, Xiaomei, Linong Ji, Xingwu Ran, et al.. (2017). Gender Disparities in Lipid Goal Attainment among Type 2 Diabetes Outpatients with Coronary Heart Disease: Results from the CCMR-3B Study. Scientific Reports. 7(1). 12648–12648. 12 indexed citations
8.
Zhang, Lin, Libin Zhan, Lina Liang, et al.. (2015). Plasma Metabolomic Profiling of Patients with Diabetes-Associated Cognitive Decline. PLoS ONE. 10(5). e0126952–e0126952. 22 indexed citations
9.
Li, Ling, Linong Ji, Xiaohui Guo, et al.. (2014). Prevalence of microvascular diseases among tertiary care Chinese with early versus late onset of type 2 diabetes. Journal of Diabetes and its Complications. 29(1). 32–37. 49 indexed citations
12.
Ji, Linong, Dayi Hu, Changyu Pan, et al.. (2013). Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients. The American Journal of Medicine. 126(10). 925.e11–925.e22. 193 indexed citations
13.
Zhang, Chunyu, et al.. (2012). Correlation analysis between thyroid nodules and metabolic syndrome and its components. Zhonghua neifenmi daixie zazhi. 28(2). 132–135. 1 indexed citations
14.
Liu, Haixia, Jing Li, Ben Liu, et al.. (2011). Effect of acarbose on fecal bifidobacteria content in patients with type 2 diabetes mellitus. Zhonghua neifenmi daixie zazhi. 27(11). 928–931. 6 indexed citations
15.
Zheng, Hong & Benli Su. (2011). Relationship between periodontal disease and diabetes mellitus. 31(3). 203–205. 4 indexed citations
16.
Zhao, Sumin, Hong Zheng, Xin Lu, et al.. (2011). Metabonomics and phospholipid metabolic profiling of abnormal glucose metabolism based on high performance liquid chromatography-electrospray mass spectrometry. Chinese Journal of Chromatography. 29(4). 307–313. 1 indexed citations
18.
Sun, Wei, et al.. (2009). -11391 G/A polymorphism in the 5′ promoter region of the APN gene contributes to the development of type 2 diabetes.. Journal of Shandong University. 47(2). 62–64. 2 indexed citations
19.
Franckhauser, Sylvie, Sergio Muñoz, Anna Pujol, et al.. (2002). Increased Fatty Acid Re-esterification by PEPCK Overexpression in Adipose Tissue Leads to Obesity Without Insulin Resistance. Diabetes. 51(3). 624–630. 182 indexed citations
20.
Üstündağ, Yücel, Ufuk Can, Benli Su, Yahya Büyükaşık, & Namık Yaşar Özbek. (2000). Internal Carotid Artery Occlusion in a Patient With Malignant Peritoneal Mesothelioma: Is It a Sign of Malignancy-Related Thrombosis?. The American Journal of the Medical Sciences. 319(4). 265–267. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026